338 related articles for article (PubMed ID: 32769881)
21. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
Hou J; Yao C
Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
[TBL] [Abstract][Full Text] [Related]
22. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
Fei H; Chen S; Xu C
Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
24. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
[TBL] [Abstract][Full Text] [Related]
25. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
26. Identification of hub driving genes and regulators of lung adenocarcinoma based on the gene Co-expression network.
Xu Z; Wu Z; Xu J; Zhang J; Yu B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32196072
[TBL] [Abstract][Full Text] [Related]
27.
Chen X; Wang Y; Qu X; Bie F; Wang Y; Du J
Future Oncol; 2021 Feb; 17(5):565-579. PubMed ID: 33406903
[No Abstract] [Full Text] [Related]
28. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma.
Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z
J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601
[TBL] [Abstract][Full Text] [Related]
29. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
30. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
31. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
32. Significance of
Hou Y; Tan S; Wang G
Genet Test Mol Biomarkers; 2021 May; 25(5):346-354. PubMed ID: 33956533
[No Abstract] [Full Text] [Related]
33. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract][Full Text] [Related]
34. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
Tian C; Li X; Ge C
Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a weighted gene co-expression network.
Yan X; Zhao X; Yan Q; Wang Y; Zhang C
Math Biosci Eng; 2021 Aug; 18(5):6608-6619. PubMed ID: 34517547
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
Li H; Tong L; Tao H; Liu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
[TBL] [Abstract][Full Text] [Related]
37. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
38. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
Wang W; He J; Lu H; Kong Q; Lin S
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
[TBL] [Abstract][Full Text] [Related]
39. CRTAC1 identified as a promising diagnosis and prognostic biomarker in lung adenocarcinoma.
Tan L; Zhang H; Ding Y; Huang Y; Sun D
Sci Rep; 2024 May; 14(1):11223. PubMed ID: 38755183
[TBL] [Abstract][Full Text] [Related]
40. An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma.
Xu Y; Lin G; Liu Y; Lin X; Lin H; Guo Z; Xu Y; Lin Q; Chen S; Yang J; Zeng Y
BMC Cancer; 2022 Feb; 22(1):188. PubMed ID: 35183135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
